
-
Louboutin taps Jaden Smith to lead well-heeled shoemaker's men's line
-
Pakistan beat UAE to set up India rematch in Asia Cup
-
US Fed makes first rate cut of 2025 over employment risks
-
US sprint star Kerley joins drug-fueled Enhanced Games
-
Decaying body found in US rapper's Tesla identified as teen girl
-
Flick backs 'unbelievable' Rashford to shine in Yamal absence
-
Mourinho poised for Benfica return after Lage sacking
-
US Fed makes first rate cut of 2025 on employment risks
-
Fired US health agency chief says was under RFK Jr 'pressure' to ignore science
-
Brazil's Bolsonaro adds skin cancer to medical woes
-
Colombia vows to fight drug trade 'with or without' the US
-
Germany's Merz criticises festival for axing Israeli conductor
-
Thousands protest in London over Trump UK visit
-
Fired US health agency chief testifies on pressure to 'replace evidence with ideology'
-
Palestinians flee Gaza City in face of deadly Israeli offensive
-
England take Salt path to victory over Ireland in first T20
-
French strikes hit Bayeux Tapestry transfer ahead of UK loan
-
New York officials sink Times Square casino bid
-
Canada central bank cuts key lending rate citing Trump tariffs
-
Pakistan Asia Cup match belatedly goes ahead amid India handshake row
-
Nader pulls off shock in 1,500 metres, Moon rises to pole vault challenge at worlds
-
Ex-US climate envoy: Trump threatening 'consensus science' worldwide
-
EU proposes action on Israel trade and ministers over Gaza
-
US Treasury official expected to be named IMF's second-in-command: source
-
Man City 'apparently' not Champions League contenders: Guardiola
-
EU says India's Russia links jeopardise closer ties
-
Ukraine reach BJK Cup semi-finals for first time
-
Benjamin sets up 'historic' hurdles showdown with Warholm and Dos Santos
-
Milan-Cortina bobsleigh track 'surpasses expectations', say Winter Olympics organisers
-
Stocks, dollar calm ahead of expected US rate cut
-
Nvidia CEO disappointed over China chip ban report
-
Portugal's Isaac Nader wins world men's 1,500m gold
-
France launches appeal to acquire Proust's 'madeleine' writings
-
East Timor to scrap MP pensions and SUVs after protests
-
Van Niekerk enjoys second wind in Tokyo after injury nightmare
-
American Moon wins third straight world pole vault gold
-
King gives Trump royal welcome on UK state visit
-
Man Utd post sixth straight annual loss despite record revenues
-
Australian teen Gout Gout revels in world championships debut
-
AI may boost global trade value by nearly 40%: WTO
-
New Zealand star Miller out of Women's Rugby World Cup semi-final
-
Lyles and Gout Gout advance to world 200m semi-finals
-
S.Africa commission begins probe into alleged links between politics and crime
-
PSG women in audacious bid to sign Barca's Putellas
-
Jefferson-Wooden eases into world 200m semis and sets sights on being next Fraser-Pryce
-
Germany's Merz vows 'autumn of reforms' in turbulent times
-
EU says India's Russian oil purchases, military drills hinder closer ties
-
Gold worth 600,000 euros stolen in Paris museum heist
-
Top music body says AI firms guilty of 'wilful' copyright theft
-
Trump gets royal treatment on UK state visit

New US strategy to make monkeypox vaccine go further
US health authorities on Tuesday authorized a new procedure for injecting the monkeypox vaccine that should make it possible to inoculate more people with the same amount of the drug, at a time when doses are running short in the country.
The Food and Drug Administration also authorized giving the vaccine to people under the age of 18 who are considered to be at high risk of infection.
For those over 18, health workers will now be able to administer the vaccine differently, via an intradermal injection -- that is, between the upper layers of the skin -- and not with a deeper, subcutaneous injection.
The new method will "increase the total number of doses available for use by up to five-fold," the FDA said in a statement.
Two injections, four weeks apart, will still be necessary.
The FDA said it was drawing on data from a 2015 clinical trial that showed a similar immune response in people given a subcutaneous injection compared to those given a fifth of the dose via an intradermal shot.
At present, some 620,000 doses of the vaccine -- manufactured by Bavarian Nordic, and marketed under the name Jynneos in the United States -- have been distributed across the country.
Another 440,000 additional doses are still to be distributed, which could allow up to 2.2 million injections under the new strategy.
The government has also ordered an additional five million doses, which will start arriving from September and run through 2023, affording the potential to administer 25 million doses.
The decisions came after the FDA issued an emergency use authorization for the vaccine, a move that itself followed the declaration of a public health emergency last week.
For the authorization in minors, the FDA said it had reviewed safety data for the vaccine, as well as data for another vaccine given in children against smallpox.
"We feel very comfortable with the safety of the approach," said Peter Marks of the FDA at a press conference, noting a recent increase in the number of children who have potentially been exposed to infected people.
The United States has registered nearly 9,000 cases of monkeypox, a fifth of them in New York state. The vast majority of cases involve men who have had sex with men.
O.Karlsson--AMWN